Showing results (61-70 of 109) with videos related to
Sort By:
Pageof 11
Haematologica|March 17, 2004
Survival of elderly patients with acute myeloid leukemiaAlessandro Pulsoni, Livio Pagano, Roberto Latagliata, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II StudyArmando Santoro, Rita Mazza, Alessandro Pulsoni, et al.British Journal of Haematology|December 14, 2011
Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genesIlaria Del Giudice, Monica Messina, Sabina Chiaretti, et al.Haematologica|September 16, 2017
Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trialsDennis A Eichenauer, Ingrid Becker, Ina Monsef, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor projectMassimo Federico, Monica Bellei, Luigi Marcheselli, et al.Annals of Hematology|December 25, 2019
The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatmentsAlessia Bari, Raffaella Marcheselli, Stefano Sacchi, et al.Haematologica|January 18, 2015
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL studyDavide Rossi, Alessio Bruscaggin, Piera La Cava, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2013
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana LinfomiMassimo Federico, Stefano Luminari, Alessandra Dondi, et al.American Journal of Hematology|October 21, 2014
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana LinfomiGiuseppe Rossi, Luigi Marcheselli, Alessandra Dondi, et al.Blood Advances|January 15, 2020
Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphomaArmando Santoro, Rita Mazza, Alessandro Pulsoni, et al.Pageof 11